On Thursday, in the course of current trade, Shares of Allstate Corp (NYSE:ALL), dropped -0.34%, and is now trading at $ 67.49.
With Allstate’s Ride for Hire endorsement, qualifying Transportation Network Company drivers can be better protected during the time they are logged into the TNC app looking for a new fare and they can benefit from lower coverage deductibles when they are on the road with TNC passengers. Allstate plans to offer coverage as an optional endorsement in four states by the end of this year.
The Allstate Ride for Hire endorsement benefits customers who use their personal vehicles to drive for qualifying TNCs. Allstate anticipates that, on average, an Allstate customer will pay roughly $15-$20 each year for the added protection.
The Allstate Corporation, through its auxiliaries, engages in the property-liability insurance and life insurance businesses in the United States and Canada.
During an Afternoon trade, Shares of McGraw Hill Financial Inc (NYSE:MHFI), dipped - 0.30%, and is now trading at $ 103.28.
The Organization of Petroleum Exporting Countries (OPEC) bestowed its 2015 Award for Journalism on Margaret McQuaile, senior correspondent at Platts, a leading global provider of energy and commodities information, before an international audience Wednesday in Vienna.
McQuaile, who has driven Platts’ OPEC coverage for many years, was also in 2006 the recipient of the International Association for Energy Economics Award for Excellence in Written Journalism.
The OPEC Award for Journalism, which was established in 2009, honors journalists for objective and balanced reporting and analysis of the oil market, contributing not only to a greater understanding of the market but also to a better awareness of the concerns and plight of developing countries. The selection process for the Award is entrusted to a panel of experts, whose recommendation is then considered and approved by OPEC’s governing board. OPEC has described Margaret’s oil and energy reporting as “outstanding.”
“On behalf of Platts, I congratulate Margaret for this well-earned recognition,” said Platts President Larry Neal. “Not only am I delighted for Margaret, but I am also delighted for Platts because the Award acknowledges the importance we place on news and analysis and the excellence on which we pride ourselves.”
Margaret is presently leading a team of Platts reporters covering this week’s OPEC talks in the Austrian capital. A seasoned journalist, her past experience also comprises market coverage of crude oil and fuel oil.
A division of McGraw Hill Financial (MHFI), Platts is based in London with more than 1000 employees in more than 15 offices worldwide.
McGraw Hill Financial, Inc. provides benchmarks and ratings, analytics, data, and research services for the capital, commodities, and commercial markets worldwide. It operates in four segments: Standard & Poor’s Ratings Services, S&P Capital IQ, S&P Dow Jones Indices, and Commodities & Commercial.
Shares of Gannett Co., Inc. (NYSE:GCI), during its Thursday’s current trading session fell - 0.31%, and is now trading at $ 36.62.
Gannett Co., Inc. declared that it has accomplished the acquisition of the remaining 59.36% interest in the Texas-New Mexico Newspapers Partnership that it did not own from Digital First Media. The deal was accomplished through the assignment of Gannett’s 19.49% interest in the California Newspapers Partnership and additional cash consideration. As a result, Gannett will own 100% of the Texas-New Mexico Newspapers Partnership and will no longer have any ownership interest in California Newspapers Partnership.
The news organizations attained and the three states in which they reside comprise:
- Texas — El Paso Times;
- New Mexico — Alamogordo Daily News; Carlsbad Current-Argus; The Daily Times in Farmington; Deming Headlight; Las Cruces Sun-News; Silver City Sun-News;
- Pennsylvania — Chambersburg Public Opinion; Hanover Evening Sun; Lebanon Daily News; and the York Daily Record.
Gannett Co., Inc. operates as a media and marketing solutions company. It operates through three segments: Broadcasting, Publishing, and Digital. The Broadcasting segment owns and operates 46 television stations that produce local programming, such as news, sports, and entertainment; and associated online sites.
Finally, Sangamo Biosciences, Inc. (NASDAQ:SGMO), lost -5.65% Thursday, hitting its highest level.
On May 18, Sangamo Biosciences, declared that new data from the company’s proprietary ZFP Therapeutic® programs in disease models of lysosomal storage disorders (LSDs) were presented last week at the 18th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT).
The data demonstrated durable expression of levels of functional enzyme sufficient to correct biomarkers of disease in mouse models of Hunter and Hurler syndromes, enabled by Sangamo’s zinc finger nuclease (ZFN)-mediated genome editing technology.
The LSD programs are part of Sangamo’s In Vivo Protein Replacement Platform (IVPRP) portfolio of ZFP Therapeutics. The IVPRP uses ZFN-mediated genome editing to precisely insert disease-corrective genes into the albumin locus in the genome of liver cells. The correct version of the enzyme, which is defective in a genetic disease, is then made by the powerful machinery that normally drives albumin expression, leading to the production and secretion of the missing enzyme by the liver.
A noteworthy and sustained reduction in glycosaminoglycan (GAG) levels (a biomarker of lysosomal storage disorder progression) was observed in the urine and secondary tissue (liver, spleen, kidneys and lungs) in Hurler and Hunter mice 21 days post treatment with ZFNs. The accumulation of GAG oligosaccharides in the lysosomes of cells leads to dysfunction in several tissues throughout the body and is associated with symptoms of these LSDs. Production of the corrective enzyme was also shown to be durable through the twelve week study, compriseent with earlier studies of the IVPRP for clotting factor, Factor IX, which demonstrated sustained production for over a year.
Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of engineered DNA-binding proteins as novel therapeutic products for unmet medical needs in the United States.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
